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The term microbiome describes the genetic material encoding the various microbial
populations that inhabit our body. Whilst colonization of various body niches (e.g.,
the gut) by dynamic communities of microorganisms is now universally accepted, the
existence of microbial populations in other “classically sterile” locations, including the
blood, is a relatively new concept. The presence of bacteria-specific DNA in the blood
has been reported in the literature for some time, yet the true origin of this is still the
subject of much deliberation. The aim of this study was to investigate the phenomenon
of a “blood microbiome” by providing a comprehensive description of bacterially derived
nucleic acids using a range of complementary molecular and classical microbiological
techniques. For this purpose we utilized a set of plasma samples from healthy subjects
(n = 5) and asthmatic subjects (n = 5). DNA-level analyses involved the amplification
and sequencing of the 16S rRNA gene. RNA-level analyses were based upon the
de novo assembly of unmapped mRNA reads and subsequent taxonomic identification.
Molecular studies were complemented by viability data from classical aerobic and
anaerobic microbial culture experiments. At the phylum level, the blood microbiome
was predominated by Proteobacteria, Actinobacteria, Firmicutes, and Bacteroidetes.
The key phyla detected were consistent irrespective of molecular method (DNA vs.
RNA), and consistent with the results of other published studies. In silico comparison
of our data with that of the Human Microbiome Project revealed that members of the
blood microbiome were most likely to have originated from the oral or skin communities.
To our surprise, aerobic and anaerobic cultures were positive in eight of out the ten
donor samples investigated, and we reflect upon their source. Our data provide further
evidence of a core blood microbiome, and provide insight into the potential source of
the bacterial DNA/RNA detected in the blood. Further, data reveal the importance of
robust experimental procedures, and identify areas for future consideration.
Keywords: blood microbiome, unmapped reads, human, next gen sequencing (NGS), biomarker (development)
BACKGROUND
The term “microbiome” describes the genetic material encoding the various microbial populations
that inhabit our body. In contrast, the term “microbiota” refers to the viable organisms that
comprise these communities. The microbiome undertakes essential biological processes and thus
it is unsurprising that a number of disease states are associated with changes in microbiome
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composition, termed “dysbiosis.” Whilst the colonization of
specific body sites in contact with the external environment (such
as the gastrointestinal tract, skin, and vagina) by microorganisms
is both well-described and universally accepted (Markova, 2017),
the existence of microbial populations in other “classically sterile”
locations, including the blood, is a relatively new concept.
The presence of bacteria-specific DNA in the blood has been
reported in the literature for some time, yet the true origin of
this is still the subject of much deliberation. Mounting evidence
supports the existence of a blood microbiome (specifically, the
presence of bacterial genetic material) in humans (Nikkari et al.,
2001; Amar et al., 2013; Rajendhran et al., 2013; Dinakaran et al.,
2014; Kell and Pretorius, 2015; Potgieter et al., 2015; Mangul
et al., 2016; Païssé et al., 2016; Bhattacharyya et al., 2017; Li
et al., 2018) and various other species, including rodents, cats,
chickens, and cows (Sze et al., 2014; Mandal et al., 2016; Jeon
et al., 2017; Vientós-Plotts et al., 2017). This has primarily been
determined by amplification and sequencing of the bacterial 16S
rRNA gene, or via whole genome sequencing. Such studies report
the existence of bacteria-derived genetic material (DNA) within
the circulation, but do not provide evidence for the presence of
viable organisms.
Convention tells us that the blood is sterile in health, and
bacteraemia, even at 1–10 bacterial cells per milliliter whole
blood, is potentially life threatening. Despite this, several studies
have presented evidence of bacteria or bacteria-like structures
within the circulation in the absence of overt disease. It should
be noted, however, that Martel et al. (2017) report that the
bacteria-like particles often described following a range of
imaging techniques represent non-living membrane vesicles and
protein aggregates derived from the blood itself. McLaughlin
et al. (2002) surveyed the blood of 25 healthy donors and
observed the presence of pleomorphic bacteria using dark-field
microscopy, electron microscopy, polymerase chain reaction and
fluorescent in situ hybridisation, in all samples analyzed. Further,
Potgieter et al. (2015) described the presence of blood-cell
associated bacteria in a range of blood preparations using electron
microscopic techniques. Significantly, Damgaard et al. (2015)
found viable (culturable) bacteria in 62% of blood donations from
donors with no overt disease. This finding is plausible given
that various daily activities including chewing, tooth brushing,
and flossing result in the translocation of oral bacteria into
the bloodstream (Forner et al., 2006; Lockhart et al., 2008;
Parahitiyawa et al., 2009; Horliana et al., 2014), however, one
would expect such organisms to be rapidly targeted and removed
with by the immune system in healthy individuals. Kell and
Pretorius (2015) provide a detailed hypothesis for the existence
of the blood microbiome (Potgieter et al., 2015) and suggest
that it is likely composed of organisms (or parts thereof) that
translocate to the circulation from their usual place of habitation
(classical niches such as the gastrointestinal tract, oral cavity, skin,
vagina) – a process termed atopobiosis. They further describe
how this could occur via well-described physiological processes
including dendritic cells processes, via micro-fold cells, and in
disease, via dysfunctional epithelial junctions. This explanation
is supported by studies demonstrating a correlation between gut
microbiota dysbiosis and altered microbial signatures detected in
the blood (Ono et al., 2005; Sato et al., 2014; Lelouvier et al., 2016),
suggesting that the observed disease-associated blood microbiota
is a consequence of increased bacterial translocation across
the gut barrier. Furthermore, characterization of the microbial
populations in the coronary artery tissues by Lehtiniemi et al.
(2005) identified known members of the oral microbiota,
suggesting that bacteria had translocated from the oral cavities
into the bloodstream, potentially as a result of damage
caused by tooth brushing or by leakage across the mucosal
surfaces.
Various disease states are associated with blood microbiome
dysbiosis (Amar et al., 2013; Sato et al., 2014; Lelouvier
et al., 2016; Mangul et al., 2016; Ling et al., 2017), and these
changes are likely reflective of dysbiosis at a distant site(s)
with well-characterized microbial communities, and the result
of subsequent translocation. Limited evidence also suggests that
these changes may be disease-specific; Alzheimer’s disease for
example, has been associated with the detection of mostly coccus
microbes, whilst Parkinson’s disease has been associated with
both coccus and bacillus bacteria (Potgieter et al., 2015). Such
changes are of significant scientific and medical interest as
they offer opportunities for biomarker and therapeutic target
development (Lelouvier et al., 2016; Ling et al., 2017).
Due to the long-held belief that the bloodstream of healthy
individuals is sterile and since the blood is an unfavorable
compartment for the microbes due to its bacteriostatic and
bactericidal components (Mandal et al., 2016; Markova, 2017),
it is of principal significance to understand whether and how
bacteria may persist in it. Accidental contamination during the
collection of blood and or during downstream experimental
procedures has been proposed as an alternative explanation
for the existence of the blood microbiome per se. We support
this explanation for the detection of viable bacteria within
the bloodstream of healthy individuals, however, suggest that
this phenomenon does not adequately explain the existence
of the blood microbiome (the presence of bacteria-derived
nucleic acids) when one considers the number of studies
that demonstrate significant and apparently disease-specific
differences in the composition of the blood microbiome.
Moreover, examination of the bacterial taxa reported in
these studies reveal similar blood microbiota compositions
across the different studies, whereby Proteobacteria dominate
(relative abundance values typically ranging from 85 to
90%), and Firmicutes, Actinobacteria, and Bacteroidetes present
to a lesser extent (Amar et al., 2013; Lelouvier et al.,
2016; Païssé et al., 2016; Olde Loohuis et al., 2018). This
suggests the existence of a core blood microbiome profile
that persists independent of study environment or analytical
methodology.
Using a range of complementary molecular and classical
molecular biology techniques, the human circulating microbiome
was characterized in unparalleled detail; at the DNA level, the
16S rRNA gene was amplified and sequenced, at the RNA level,
almost 500,000,000 unmapped mRNA reads were assembled
and mapped to known taxa, and finally, viability data was
generated using classical aerobic and anaerobic microbial culture
experiments. The experimental approach is detailed in Figure 1.
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FIGURE 1 | Schematic representation of the multiple-method circulating microbiome characterization approach implemented herein. NB: Biomarker and
mechanistic data are not included within the scope of this publication and appear elsewhere.
MATERIALS AND METHODS
Donor Samples
Atopic asthmatic individuals (n = 5) with physician-diagnosed
house dust mite allergy, and gender and age-matched healthy
control subjects (n = 5) were recruited to the study via SeraLabs
Limited in accordance with the following criteria (Table 1).
Whole blood was drawn, following alcohol cleansing of the skin
surface, into EDTA containing tubes and stored on ice prior to
centrifugation at 1000 × g to obtain the plasma component. All
samples were analyzed anonymously, and the authors obtained
ethical approval (Keele University ERP3) and written informed
consent to utilize the samples for the research reported herein.
DNA-Level: Meta-Taxonomic
Characterization
The circulating microbiome was investigated at the DNA level
by amplification and sequencing of the bacterial 16S ribosomal
gene using oligonucleotide primers that target variable region
4 (Kozich et al., 2013) (Table 2). Direct amplification of the
V4 region was performed using the Phusion Blood Direct kit
(Thermo Fisher Scientific) alongside a negative control reaction
(in which blood was replaced with molecular biology grade
water) that underwent the complete experimental procedure.
Amplification was performed in triplicate as 20 µl reactions
containing; 1.0 µl plasma, 10 µl 2X Phusion blood PCR buffer,
0.4 µl Phusion Blood II DNA polymerase, 1.0 µl of each forward
TABLE 1 | Donor population characteristics.
Patient Criteria
• Have a BMI < 30
• Be non-smokers
• Were diagnosed with atopic asthma during childhood
• Have severe/ poorly controlled symptoms
• Are not on current oral steroid treatment
• Must be allergic to house dust mite
• Must not have diabetes, COPD, or hypertension
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and reverse oligonucleotide primer (10 µM), and 6.6 µl of UV-
treated molecular biology grade water. Cycling parameters were
as follows; an initial 5 min denaturation step at 98◦C followed by
33 cycles of; denaturation (1 s at 98◦C), annealing (5 s at 55◦C),
and extension (15 s at 72◦C), and a final extension at 72◦C for
7 min.
Amplicons resulting from triplicate reactions were combined
and purified using the MinElute PCR purification kit (Qiagen)
prior to a further 7 cycles of PCR using AccuPrime Pfx
SuperMix and a pair of V4 oligonucleotide primers we developed
to incorporate the Illumina XT adapter in preparation for
sequencing (Table 2). Cycling parameters were as follows;
initial denaturation for 2 min at 95◦C followed by 7 cycles
of; denaturation (15 s at 95◦C), annealing (30 s at 55◦C), and
extension (25 s at 68◦C), and a final extension at 68◦C for 10 min.
PCR products were purified using the AMPure XP magnetic
beads (Agencourt) at a ratio of 0.8 beads to sample (v/v), eluted
in 20 µl molecular biology grade water, and quantified using the
Qubit 3.0 high-sensitivity DNA kit. Amplicons were barcoded
using the Nextera DNA library kit, multiplexed, and sequenced
using the Ilumina MiSeq system with a 250 bp paired-end
read metric. Bioinformatic analysis was performed using QIIME
(Caporaso et al., 2010) implemented as part of the Nephele
16S paired-end QIIME pipeline using closed reference clustering
against the SILVA database (Quast et al., 2013) at a sequence
identity of 99%. All other parameters remained as default.
RNA-Level: De novo Assembly of
Unmapped RNA Reads
For the purposes of increasing our understanding of the
molecular processes that are deregulated in patients with
atopic asthma, we previously performed whole transcriptome
sequencing on RNA extracted from each donor plasma sample
(data currently unpublished). Here, we hypothesized that the
non-mapping (likely non-human) reads that often result from
such analyses would represent microbial community members
that were present in the blood at the time of RNA extraction.
To this end, RNA reads were mapped to the Homo sapiens
genome version hg38 using Tophat with default parameters
(Trapnell et al., 2012). Reads failing to map to hg38 were
identified from the resulting BAM file and reads, in fastq format,
extracted using bedtools bamtofastq. In order to streamline
our strategy, a single de novo transcriptome was produced
by concatenating all of the unmapped reads produced from
the entire study, and assembling these using Trinity (Haas
et al., 2013) to form features representative of candidate non-
human genes. To increase computational efficiency, the total
read population was subsampled to a depth of 1, 10, 25, and
100 M, and the number of reads that these features explained
computed by building a bowtie2 index out of each resulting
transcriptome, and mapping the unmapped read population
from each sample back to it. The transcriptome assembly with
the highest mapping rate was used for further analysis as
follows: (1) Abundance estimation – the transcriptome was
indexed for bowtie2 and the number of reads mapping to
each feature determined for each of our donor samples using
RSEM (Li and Dewey, 2011). (2) A matrix of expression values
was produced using the abundance_estimates_to_matrix.pl
script packaged with Trinity (Grabherr et al., 2011). (3)
Statistical analysis – a differential expression analysis was
conducted to identify candidate non-human genes that were
significantly differentially expressed between the disease and
disease-free donors using edgeR (Robinson et al., 2010). (4)
Identification – the taxonomic identity of each assembled
feature was determined using Kraken (Wood and Salzberg,
2014) and visualized using Pavian (Breitwieser and Salzberg,
2016).
Classical Culture: Bacterial Viability
Classical microbiological culture, using a range of substrates,
was carried out to determine whether the human plasma
samples contained any viable bacterial cells, i.e., those capable
of proliferation. For each sample, 250 µl plasma was inoculated
into 9 ml of brain heart infusion broth and incubated for 5 days
at 37◦C. For each culture a negative control was generated,
whereby 9 ml of brain heart infusion broth was inoculated with
250 µl of ultra-violet sterilized distilled water and incubated
for 5 days at 37◦C. The inoculated broth was plated onto
agar plates (Columbia agar + 5% horse blood; CLED medium;
A.R.I.A + horse blood) and incubated under either aerobic
(Columbia blood agar; CLED medium) or anaerobic (A.R.I.A
agar) conditions at 37◦C for a minimum of three days. Bacterial
growth was evaluated by sight, and a selection of individual
colonies from each plate was selected for identification by total
16S gene amplification and Sanger sequencing.
RESULTS AND DISCUSSION
Donor Characteristics
This study utilized samples originally sourced for the molecular
characterization of asthma pathogenesis1. The donor population
were all female (due to the characteristics of the clinical donor
population at the time of collection), and all “never smokers.”
The asthmatic population were 39.6 years in age (range 19–52)
with a mean body mass index of 24.4 (range 21.5–27.8) and
all had physician-diagnosed atopic asthma resulting from house
dust mite allergy. The control population were 39.4 years in age
(range 23–49) with a mean body mass index of 24.3 (range 21.0–
26.4) and were disease-free. There were no statistically significant
differences in age (P = 0.98) or BMI (P = 0.93) between the two
groups (Table 3).
DNA-Level Circulating Microbiome –
Community Structure
The presence of bacterial DNA within the blood of our study
cohort was evaluated by amplification and sequencing of the
16S RNA gene variable region 4. A negative experimental
control sample mirrored our study samples through the entire
experimental procedure downstream of venepuncture. This
involved using ultra-violet treated molecular biology-grade water
in replacement of human blood during PCR amplification of
1https://doi.org/10.1101/446427
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TABLE 2 | Oligonucleotide primer sequences.
Primer Name Sequence (5′–3′) Length
V4_F GTGCCAGCMGCCGCGGTAA 19
V4_R GGACTACHVGGGTWTCTAAT 20
V4_XT_F TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTGCCAGCMGCCGCGGTAA 52
V4_XT_R GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGGACTACHVGGGTWTCTAAT 54
TABLE 3 | Donor population characteristics.
Donor Age (years) BMI (kg/m2) Smoking History Diagnosis
BRH1017873 50–60 27.8 Never Atopic Asthma, HDM
BRH1017874 30–40 27.3 Never Atopic Asthma, HDM
BRH1017875 40–50 23.3 Never Atopic Asthma, HDM
BRH1017876 10–20 21.5 Never Atopic Asthma, HDM
BRH1017877 40–50 22.3 Never Atopic Asthma, HDM
BRH1017878 40–50 26.4 Never Healthy
BRH1017879 20–30 21 Never Healthy
BRH1017880 40–50 26.4 Never Healthy
BRH1017881 40–50 24.9 Never Healthy
BRH1017882 30–40 22.7 Never Healthy
the 16S rRNA V4 region. The negative control PCR product
was then submitted to all downstream applications that the
human blood underwent. This included bead-based purification
of the 16S rRNA V4 amplicons, agarose gel electrophoresis, XT-
tagging, library preparation and sequencing of the 16S rRNA V4
amplicons.
Using QIIME (Caporaso et al., 2010) implemented as part
of Nephele, a total of 243, 853 sequencing reads from the
amplified V4 region passed quality assessment (mean = 24,385
reads per sample; range = 10,742–35,701 reads). The results of
our taxonomic classification are shown in (Figures 2A–D) at the
phylum and genus levels.
Our negative control reaction generated a small number
of reads that were identified as the following genera;
Halomonas (6 reads), Corynebacterium (64), Staphylococcus
(24), Ralstonia (1726), Stenotrophomonas (460), Pseudomonas
(276), Escherichia-Shigella (2420), and Ruminococcus (405),
but was overwhelmingly composed of reads mapping to the
genus Serratia (18000). These genera have been reported
previously as contaminants of next generation sequencing
experiments (Laurence et al., 2014; Salter et al., 2014)
but importantly here, were either distinct from the taxa
identified within our samples, or present at much lower
levels.
At the phylum level, the blood microbiome was predominated
by Proteobacteria (88% of all bacterial DNA in the control
population, and 80.9% in the asthmatic population) followed by
Actinobacteria (control = 7.8%, asthmatic = 7.1%), Firmicutes
(control = 3.5%, asthmatic = 9.2%) and Bacteroidetes
(control = 0.1%, asthmatic = 2.2%). These findings mirror
previous studies (Amar et al., 2013; Lelouvier et al., 2016; Païssé
et al., 2016; Olde Loohuis et al., 2018) and further support the
notion of a core blood microbiome predominated by four key
phyla.
At the genus level, our blood samples were predominated by
the genus Achromobacter (Gyarmati et al., 2016) which accounted
for 51.1 and 45.3% of the total bacterial DNA detected in the
control and asthma donors, respectively. To a lesser extent, the
blood samples also comprised members of the Pseudomonas
(12.8%, 7.5%) (Dinakaran et al., 2014; Damgaard et al., 2015;
Païssé et al., 2016), Serratia∗ (0.9%, 11.6%) (Moriyama et al.,
2008), Sphingomonas (3.8%, 5.1%) (Lelouvier et al., 2016; Païssé
et al., 2016), Staphylococcus (5.5%, 2.8%) (Such et al., 2002;
Marques da Silva et al., 2003; Damgaard et al., 2015; Païssé
et al., 2016), Corynebacterium (3.2%, 5.5%) (Dinakaran et al.,
2014; Païssé et al., 2016), and Acinetobacter (3.7%, 2.8%) (Païssé
et al., 2016) genera. The genus Serratia was excluded from further
analysis as the study samples presented with less reads than
did the corresponding negative control reaction and thus it was
considered a contaminant.
Whilst all genera found have been previously described in
the blood (see references), the predominance of Achromobacter,
which is not classically associated with the blood microbiome,
warrants further consideration. Indeed, Achromobacter
has been detected abundantly in the lower respiratory
tract of healthy mice (Singh et al., 2017), humans (HPM
airway dataset), and in various respiratory conditions
(Segal et al., 2014; Hogan et al., 2016). Furthermore, no
Achromobacter was detected in our experimental control
reactions suggesting that its presence is not the result of
experimental contamination.
Although differential composition of the blood microbiome
in response to pathology was not the main focus of this study,
we performed principal coordinates analysis and despite the
relatively small sample set, this revealed good separation between
the two treatment groups based upon their microbiome profile,
suggesting that the blood microbiome community was altered in
the asthmatic subjects (Figure 3).
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FIGURE 2 | Relative abundance of the most abundant taxa (>1%) as determined by amplification and sequencing of the 16S rRNA gene variable region 4. Data are
mean abundance expressed as a percentage of the total bacterial sequence count. (A) Phylum-level data grouped by condition, (B) Genus-level data grouped by
condition, (C) Phylum-level individual sample data, and (D) Genus-level individual sample data.
FIGURE 3 | Principal coordinates analysis of weighted unifrac distances for
control (blue) and asthmatic (red) blood microbiome profiles. Each dot
represents an individual sample, and the microbiome of samples that appear
more closely together are more similar.
DNA-Level Circulating Microbiome –
Likely Origins
In accordance with our hypothesis that the blood microbiome
exists as a consequence of bacterial translocation from other
microbiome niches within the body, we compared the data
generated herein with gastrointestinal tract, oral cavity, and
skin data made available by the Human Microbiome Project
(HMP). In each case, the HMP data and our own were
combined, weighted UniFrac distances calculated, and a principal
coordinates analysis performed. Figure 4 demonstrates that the
blood microbiome of our control and asthmatic donors clustered
more closely in PCoA space with the oral cavity and skin HMP
data, than it did with the gastrointestinal tract HMP data. This
suggests that the blood microbiome community is perhaps more
likely to result from the translocation of organisms from the
oral cavity and skin, than from organisms that colonize the
gastrointestinal tract.
Various daily activities including chewing, tooth brushing
and flossing have been shown to result in the translocation
of bacteria from the oral cavity into the bloodstream (Forner
et al., 2006; Lockhart et al., 2008; Parahitiyawa et al., 2009;
Horliana et al., 2014). Further, the skin has a distinct microbial
community and is susceptible to injury, and thus represents a
large surface area through which such organisms may translocate
to the bloodstream. It is important here to consider sources
of contamination; venepuncture, the process through which the
majority of blood samples are obtained, is recognized as a cause
of transient bacteraemia (Depcik-Smith et al., 2001), and despite
the use of preventative measures such as alcohol cleansing of the
skin prior to breaking the surface, there remains the possibility
that organisms entered the sample from the skin via this route.
One important, but often overlooked limitation of DNA-based
microbiome characterization is that DNA persists post-mortem,
even in the presence of harsh environmental conditions. From
such analyses it is therefore impossible to confirm whether an
organism is present and viable, is present but non-viable, or
whether the organism has since left the environment in question
yet it’s DNA persists.
RNA-Level Circulating Microbiome –
Community Structure
We hypothesize that some of the non-mapping (likely non-
human) reads that often result from whole transcriptome
analyses (RNA-seq) represent microbial community members
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FIGURE 4 | Principal coordinates analysis of weighted unifrac distances between variable region 4 16S sequencing data from our donors and the Human
Microbiome Project Gut, Oral Cavity, and Skin data. Each dot represents an individual sample, and the microbiome of samples that appear more closely together are
more similar. In each case, our control donor samples appear in blue, and our asthmatic donor samples appear in red. Further sample details are provided beneath
each figure, and the number of datasets representing each anatomic location is provided in brackets.
that were present (or parts thereof) in the blood at the time
of RNA extraction. Furthermore, given the unstable nature of
extracellular circulatory RNA (Tsui et al., 2002) in addition to
the presence of circulatory ribonucleases that actively degrade
RNA (Segal et al., 2014), we suggest that the detection of
bacterial RNA goes further toward confirming the recent
presence of these microbes within the blood when compared
with DNA-based approaches. From our previous studies of the
circulating transcriptome of our donor community, a total of
439,448,931 paired RNA reads failed to map to the human
genome. These reads were used for the following analyses
as randomly subsampled populations of 1, 10, 25, and 100
million read pairs. Mapping the total read population back
to the subsampled populations allowed us to assess how
well each subsampled population approximated the starting
(entire, ∼ 440 M read) population. Data revealed only
marginal improvements in whole community representation as
the subsampled population increased (1, 10, 25, and 100 M
represented 65.05, 66.05, 66.81, and 64.24% of the total read
population). A subsampled population of 25 million reads (25 M)
provided an acceptable balance between read representation
and computational efficiency and was therefore used for
transcriptome assembly. The transcriptome comprised 2050
candidate “non-human genes” with a mean GC content of
53%. Ten-percent of these genes were greater than 517 bp,
and over half were at least 263 bp. Taxonomic identification of
each assembled feature was determined using Kraken (Wood
and Salzberg, 2014) and this revealed that 729 of the 2050
features were of bacterial origin and seven features were from
archaea [pertaining to the taxa Thermoplasmata, which has
been previously associated with the human microbiome (Lurie-
Weinberger and Gophna, 2015)] (Figure 5). Although we
identified 13 features of apparent viral origin, we did not consider
these in any further detail given they appeared to pertain to the
Moloney murine leukemia virus, a commonly utilized reverse
transcriptase used in molecular procedures. It should be noted
that the Kraken database does not include fungi, and therefore
this kingdom was not represented within our data.
At the phylum level, the whole transcriptome data was
predominated by assembled Proteobacteria sequences (379
sequences, 52%), followed by Firmicutes (143, 19.8%),
Actinobacteria (112, 15.5%) and Bacteroidetes (35, 4.8%). In
considering the total number of reads mapping to each feature,
379.4 M reads mapped to bacterial features (out of a total of
395 M reads). Of those reads mapping to bacterial-derived
sequences, Proteobacteria (74.9%, 47.0%; Control, Asthma) and
Firmicutes (19.5%, 48.0%) predominated with, Actinobacteria
(0.01%, 0.04%) and Bacteroidetes (0.05%, 0.008%) present to
a much lesser extent. These findings support our DNA-level
phylum data and mirror previous studies (Amar et al., 2013;
Lelouvier et al., 2016; Païssé et al., 2016; Olde Loohuis et al.,
2018).
At the genus level, the whole transcriptome data was
predominated by the genera Paenibacillus (17.8%, 44.6%;
Control, Asthma reads) (Sáez-Nieto et al., 2017), Escherichia
(11.8%, 13.1%) (Such et al., 2002; Francés et al., 2004;
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FIGURE 5 | Taxonomic classification of each feature assembled from unmapped RNA sequencing reads using Trinity and identified using Kraken. The numbers
present by each taxonomic classification refer to the number of features classified as such (e.g., 379 assembled features were identified as Proteobacteria). D –
domain, P – phylum, F – family, G – genus, S – species.
FIGURE 6 | Taxonomic classification of total 16S data generated by colony PCR and Sanger sequencing. The numbers present by each taxonomic classification
indicate the number of colonies that were identified with that identity. D – domain, P – phylum, F – family, G – genus, S – species.
Dinakaran et al., 2014; Païssé et al., 2016), Acinetobacter (0.7%,
0.4%) (Païssé et al., 2016), Pseudomonas (0.8%, 0.1%) (Bhatt
et al., 2014; Dinakaran et al., 2014; Damgaard et al., 2015; Païssé
et al., 2016) and Propionibacterium (0.5%, 0.2%) (Marques da
Silva et al., 2003; Bhatt et al., 2014; Dinakaran et al., 2014;
Damgaard et al., 2015). With the exception of Paenibacillus,
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.
all genera detected via de novo transcriptome assembly were
also present in our DNA-level data and all genera found have
been previously described in the blood (see references). The fact
that Paenibacillus was present within our RNA-level analyses yet
absent from our DNA-level data led us to consider whether it
could have been introduced as a contaminant during the RNA
extraction, library preparation or sequencing procedures. Given
that negative control reactions are not routinely conducted for
RNA-seq type applications, we were unable to experimentally
confirm this. However, we did identify from the literature that
this genus has been reported as a common reagent and laboratory
contaminant, albeit at the DNA level (Salter et al., 2014).
Nevertheless there appeared to be little consistency in its presence
within our sample set (mean % of reads 39.5 ± 40.3%) and
we noted a difference in abundance between our experimental
groups despite all preparation procedures being the same. The
exact source of this RNA thus remains open to speculation.
Classical Culture – Presence of Viable
Organisms
The presence of viable, proliferating bacteria in the blood was
assessed using growth culture assays as previously described.
Bacterial cultures were positive for 80% of blood samples assayed
(8 out of 10 samples; 4 control blood samples and 4 asthma
blood samples), whilst all negative control plates had no growth
as expected. Negative cultures were repeated on two further
occasions to confirm this status. These results are relatively
consistent with previous studies, whereby 2–100% of blood
samples were positive for bacterial growth (Wilson et al., 1975;
Domingue and Schlegel, 1977; Jiménez et al., 2005; Damgaard
et al., 2015; Panaiotov, 2018). Unexpectedly, bacterial growth
was observed in aerobic conditions for all culture-positive blood
samples, but anaerobic growth was only observed for four of
the culture-positive blood samples. This is contradictory to
previous studies, where bacterial growth from blood-cultures
has predominately been achieved using anaerobic conditions
(Jiménez et al., 2005; Damgaard et al., 2015).
In all instances, bacterial growth was monoculture on
microscopy and thus 16S colony PCR (amplifying the entire
16S rRNA gene) and Sanger sequencing was conducted on a
three independent colonies per plate for identification purposes.
Bacteria were identified using Sanger sequencing followed by
classification with Kraken. Bacteria isolated from the aerobic
cultures included the following genera; Staphylococcus (49
sequences), Micrococcus (12), Kocuria (6), Corynebacterium
(6) and Propionibacterium (1). Bacteria isolated from the
anaerobic cultures were less variable and included members
from the facultatively anaerobic Staphylococcus genus only
(Figure 6). These genera belong to the phyla Actinobacteria
(Corynebacterium, Kocuria, Micrococcus) and Firmicutes
(Staphylococcus) and were all represented in our 16S DNA level
data (Figure 4) and detected within our RNA data. Individual
sample data is presented in Table 4. It is noteworthy that,
with the exception of Kocuria, all bacteria identified displayed
some of the highest total relative abundance scores in the 16S
sequencing results; Corynebacterium (4.2%), Kocuria (0.2%),
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Micrococcus (1.30%), and Staphylococcus at 4.3%. Due to the
long-held belief that the bloodstream of healthy individuals
is sterile and since the blood is an unfavorable compartment
for the microbes due to its bacteriostatic and bactericidal
components; here we consider the likely source of these viable
organisms. The skin microbiome is dominated by members of
the genera Corynebacterium, Micrococcus, Staphylococcus, and
Propionibacterium, the proportions of which vary markedly
between individuals (Tett et al., 2017). Furthermore, several
studies report the presence of the genus Kocuria on the skin
of humans and other mammals (Grice et al., 2008; Cosseau
et al., 2016; McIntyre et al., 2016). We therefore suggest that the
organisms detected through our microbial culture experiments
most likely originate from the skin. Whilst transient bacteraemia
due to a breach of the skin barrier is an accepted occurrence, one
would expect such organisms to be rapidly targeted and removed
by the immune system.
We therefore suggest that the viable organisms detected
through classical microbial culture analysis are the result of
venepuncture contamination whereby organisms from the skin
are drawn into the vacutainer, contaminating the sample. An
alternative hypothesis suggests that these bacteria were present
in the blood in a dormant state (i.e., not contaminants), and were
somehow revived following pre-growth in brain heart infusion
broth prior to plating [see Kell and Pretorius, 2015 for a detailed
description of this hypothesis (Potgieter et al., 2015)], however,
this hypothesis is still under intense investigation.
CONCLUSION
This study utilized a range of molecular and classical
microbiology approaches to characterize the human blood
microbiome in unparalleled detail. Our DNA and RNA-based
studies revealed a diverse community of bacteria, the main
members of which having been described in a range of other
studies and therefore providing further evidence of a core blood
microbiome. Although disease associated changes in the blood
microbiome were not the focus of this study, the fact we identified
such changes is encouraging and supports efforts to identify
circulating microbiome signatures indicative of disease.
Whilst we attribute the finding of viable organisms in our
plasma samples to venepuncture-associated contamination of
the blood sample (and make recommendations to avoid this in
future) and or the phenomena of dormancy, the presence of these
viable organisms does not undermine our exciting molecular
data that reports an abundance of bacteria-associated DNA and
RNA within the blood, likely present due to translocation from
classical microbiome niches (such as the gut, oral cavity and skin),
and with the clear potential to be developed as a biomarker of
microbiome status at distant anatomical sites.
On reflecting upon our experimental approach, we make the
following recommendations for future studies:
(1) Significant attention should be paid to blood collection
procedures as any contamination occurring at this stage
impacts upon all downstream procedures. In addition to
alcohol cleansing of the skin (as performed in this study),
we recommend that the first volume drawn is diverted
to a secondary tube, and analyzed separately. This will
allow investigation of the contribution that venepuncture-
associated contamination makes, and allow robust analysis
of the dormancy hypothesis.
(2) The inclusion of negative control reactions that are subject
to the whole range of experimental procedures, including
library preparation and sequencing, is absolutely essential.
(3) Where possible, RNA-seq studies used for unmapped read
assembly should include negative control samples that are
subject to all of the experimental procedures alongside
the study samples. This will allow an appraisal of how
significant reagent/laboratory procedure contamination
is in these studies. Often the use of RNA-seq derived
unmapped reads for microbiome characterization is a
“secondary use,” and this is simply not possible.
(4) Seminal studies are still required to satisfactorily investigate
the phenomenon of bacterial translocation from well-
characterized microbiome niches to the blood.
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